Meera Pal is a Northern California-based writer with a background in journalism and books. She covers pets, real estate, tech, and everything in between. You can follow her on Twitter @Meerakat Kelly ...

The IDEXX Cancer Dx Panel has already transformed cancer screening for veterinarians. Today, more than 5,500 practices across ...

In dogs, mast cell tumors are the most common malignant skin tumors, accounting for approximately 16–21% of all skin cancers. These tumors can appear anywhere on the body but are most frequently found ...

Q: My Lab mix has a mast cell tumor. What can you tell me about this condition? A: A mast cell tumor is the most common form of skin cancer in dogs. Mast cells are white blood cells designed to fight ...

Canine mast cell tumours (MCTs) represent one of the most prevalent neoplasms in dogs, characterised by their markedly heterogeneous clinical behaviour. These tumours, ranging from benign lesions to ...

SILVER SPRING, Md., Nov. 16, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous ...

Editor’s note: Dr. Lee Pickett has retired, but Creators continues to distribute columns from her archive. This one is from 2022. Q: My Lab mix has a mast cell tumor. What can you tell me about this ...

HOUSTON - It’s good news for dog owners who have concerns about skin tumors on their pooch. A new FDA-approved drug claims to cure most mast cell tumors, in some cases with only a single injection. A ...

Mast cell tumors (MCTs) are among the most common skin cancers affecting dogs and cats. These tumors originate from mast cells – immune cells that play a key role in allergic reactions and ...

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also ...